Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             70 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Antioxidant Therapies for Traumatic Brain Injury Hall, Edward D.
2010
7 1 p. 51-61
11 p.
artikel
2 Antioxidant therapies for traumatic brain injury Hall, Edward D.
2010
7 1 p. 51-61
artikel
3 Biomarkers for the Diagnosis, Prognosis, and Evaluation of Treatment Efficacy for Traumatic Brain Injury Dash, Pramod K.
2010
7 1 p. 100-114
15 p.
artikel
4 Biomarkers for the diagnosis, prognosis, and evaluation of treatment efficacy for traumatic brain injury Dash, Pramod K.
2010
7 1 p. 100-114
artikel
5 Break and poster viewing 2010
7 1 p. 136-
1 p.
artikel
6 Calpain as a Therapeutic Target in Traumatic Brain Injury Saatman, Kathryn E.
2010
7 1 p. 31-42
12 p.
artikel
7 Calpain as a therapeutic target in traumatic brain injury Saatman, Kathryn E.
2010
7 1 p. 31-42
artikel
8 Cell Death Mechanisms and Modulation in Traumatic Brain Injury Stoica, Bogdan A.
2010
7 1 p. 3-12
10 p.
artikel
9 Cell death mechanisms and modulation in traumatic brain injury Stoica, Bogdan A.
2010
7 1 p. 3-12
artikel
10 Clinical Trials in Traumatic Brain Injury: Past Experience and Current Developments Maas, Andrew I.R.
2010
7 1 p. 115-126
12 p.
artikel
11 Clinical trials in traumatic brain injury: Past experience and current developments Maas, Andrew I. R.
2010
7 1 p. 115-126
artikel
12 Contents 2010
7 1 p. ii-iii
nvt p.
artikel
13 Editorial Board 2010
7 1 p. i-
1 p.
artikel
14 IMPACT Recommendations for Improving the Design and Analysis of Clinical Trials in Moderate to Severe Traumatic Brain Injury Maas, Andrew I.R.
2010
7 1 p. 127-134
8 p.
artikel
15 IMPACT recommendations for improving the design and analysis of clinical trials in moderate to severe traumatic brain injury Maas, Andrew I. R.
2010
7 1 p. 127-134
artikel
16 Introduction—Introduction and acknowledgments Cha, Jang-Ho
2010
7 1 p. 135-
1 p.
artikel
17 Involvement of Pro- and Anti-Inflammatory Cytokines and Chemokines in the Pathophysiology of Traumatic Brain Injury Ziebell, Jenna M.
2010
7 1 p. 22-30
9 p.
artikel
18 Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury Ziebell, Jenna M.
2010
7 1 p. 22-30
artikel
19 Keynote address—FDA Regulation of Stem Cell Therapy Witten, Celia
2010
7 1 p. 137-
1 p.
artikel
20 Keynote address—Huntington's Advocacy: Why I Care Roberson, Judy
2010
7 1 p. 135-
1 p.
artikel
21 Keynote address—Working Toward Mesenchymal Stem Cell Therapy for HD Nolta, Jan
2010
7 1 p. 136-
1 p.
artikel
22 Mitochondrial Damage: A Target for New Therapeutic Horizons Soustiel, Jean F.
2010
7 1 p. 13-21
9 p.
artikel
23 Mitochondrial damage: A target for new therapeutic horizons Soustiel, Jean F.
2010
7 1 p. 13-21
artikel
24 Platform presentation—Early Defect of Transforming Growth Factor β1 Formation in Huntington's Disease Battaglia, G.
2010
7 1 p. 135-136
2 p.
artikel
25 Platform presentation—Early vs Late Huntington's Disease: Is There a Difference in Psychiatric Symptom Severity? Anderson, K.
2010
7 1 p. 136-
1 p.
artikel
26 Platform presentation—Impairments in Precision Grip Control in Pre-symptomatic Huntington's Disease Rao, A.
2010
7 1 p. 136-
1 p.
artikel
27 Platform presentation—Late-breaking research—Multivariate Clinical Predictors of Huntington Disease (HD): Prospective Results from the PREDICT-HD Study Langbehn, D.
2010
7 1 p. 137-
1 p.
artikel
28 Poster 15: A Successful Short- and Long-Term Recruiting Strategy for Huntington Clinical Trials: A Community Effort Goodman, L.
2010
7 1 p. 142-143
2 p.
artikel
29 Poster 1: Caregiver Quality of Life in Huntington's Disease Cox, M.
2010
7 1 p. 138-
1 p.
artikel
30 Poster 6: Cerebrospinal Fluid (CSF) Volume Is the Main Marker of Huntington Disease Progression Severity and Age-at-Onset Prediction Squitieri, F.
2010
7 1 p. 139-140
2 p.
artikel
31 Poster 27: Characterizing Psychomotor Declines in Prodromal Huntington Disease with the Trail Making Test O'Rourke, J.
2010
7 1 p. 147-
1 p.
artikel
32 Poster 10: Degree of Disability Is Predictive of Physical But Not Mental Health Quality of Life in Huntington's Disease Robottom, B.
2010
7 1 p. 141-
1 p.
artikel
33 Poster 28: Delphi Process for the Development of Treatment Guidelines for Behavioral Symptoms and Chorea in Huntington's Disease van Duijn, E.
2010
7 1 p. 147-
1 p.
artikel
34 Poster 7: Early Defect of Transforming Growth Factor β1 Formation in Huntington's Disease Battaglia, G.
2010
7 1 p. 140-
1 p.
artikel
35 Poster 21: EURO-HDB—The First Large, Comprehensive European Study on the Burden of Huntington's Disease Dorey, J.
2010
7 1 p. 145-
1 p.
artikel
36 Poster 14: Evaluation of Novel Radiotracers Targeting Non-Dopaminergic Striatal Biomarkers in HD: 18F-FPEB and PET Imaging for Metabotropic Glutamate Receptor Type 5 (mGluR5) Expression in Healthy Subjects and Subjects with Huntington Disease (HD) Russell, D.
2010
7 1 p. 142-
1 p.
artikel
37 Poster 3: Frequency of Epileptic Seizures in a Population of Juvenile Huntington's Disease Patients Cloud, L.
2010
7 1 p. 138-139
2 p.
artikel
38 Poster 16: Genetic Approach to Huntington's Disease Therapeutics MacDonald, M.
2010
7 1 p. 143-
1 p.
artikel
39 Poster 2: Genetic Discrimination of Individuals at Risk of Huntington's Disease: Further Analysis of the RESPOND-HD Data From Australia (Site 144) Goh, A.
2010
7 1 p. 138-
1 p.
artikel
40 Poster 13: Huntington's Disease Disrupts Motor Control Mechanisms That Rely on Internal Models Cortes, J.C.
2010
7 1 p. 142-
1 p.
artikel
41 Poster 18: Lack of Awareness of Motor and Cognitive Phenoconversion in Huntington's Disease Richardson, K.
2010
7 1 p. 144-
1 p.
artikel
42 Poster 25: Longitudinal Analysis of the UHDRS in Individuals At-Risk for Huntington's Disease by Gene Status: The Prospective Huntington's Disease Observational At-Risk Study (PHAROS) 2010
7 1 p. 146-
1 p.
artikel
43 Poster 17: Metabolic Profiling in Non-Human Primate Model of Huntington's Disease Reveals Early Disruptions in Tryptophan Metabolism Johnson, J.
2010
7 1 p. 143-
1 p.
artikel
44 Poster 29: Multivariate Clinical Predictors of Huntington Disease (HD): Prospective Results from the PREDICT-HD Study Langbehn, D.
2010
7 1 p. 147-
1 p.
artikel
45 Poster 23: Pharmacology of the Dopaminergic Stabilizer Pridopidine (ACR16) Waters, S.
2010
7 1 p. 145-146
2 p.
artikel
46 Poster 20: Pridopidine (ACR16) in Huntington's Disease: An Update on the MermaiHD and HART Studies Tedroff, J.
2010
7 1 p. 144-145
2 p.
artikel
47 Poster 8: Reliability of the Problem Behaviours Assessment for HD (short version)–Data From the TRACK-HD Study Callaghan, J.
2010
7 1 p. 140-
1 p.
artikel
48 Poster 12: Self-Efficacy in Health Behaviors: Is There a Difference in Huntington vs Parkinson Disease? Mitchell, A.
2010
7 1 p. 141-142
2 p.
artikel
49 Poster 11: Striatal Volume Distinguishes Converters from Non-Converters: Findings from PREDICT-HD Aylward, E.
2010
7 1 p. 141-
1 p.
artikel
50 Poster 4: The Effect of Video Game-Based Exercise on Dynamic Balance and Mobility in Individuals with Huntington's Disease Kegelmeyer, D.
2010
7 1 p. 139-
1 p.
artikel
51 Poster 22: The Huntington Self-Assessment Instrument (HSAI): A Comprehensive and Specific Tool to Measure the Burden of Huntington's Disease Tedroff, J.
2010
7 1 p. 145-
1 p.
artikel
52 Poster 9: The Short Version of the Problem Behaviours Assessment for HD (PBA-s): An Item Response Analysis Using Data from the TRACK-HD Study Evans, K.
2010
7 1 p. 140-
1 p.
artikel
53 Poster 5: Usefulness of Two Brief Cognitive Screening Measures in Huntington's Disease Lessig, S.
2010
7 1 p. 139-
1 p.
artikel
54 Poster 19: Validation of the Modified Motor Score (mMS): A Subscale of the Unified Huntington's Disease Rating Scale (UHDRS) Motor Score Waters, S.
2010
7 1 p. 144-
1 p.
artikel
55 Poster viewing 2010
7 1 p. 135-
1 p.
artikel
56 Poster 26: Word Reading Compared to Demographics-Based Estimates of Premorbid IQ in Early Huntington Disease Adams, W.
2010
7 1 p. 146-147
2 p.
artikel
57 Poster 24: Worry and Experience of Genetic Discrimination in Persons at Risk for Huntington Disease Erwin, C.
2010
7 1 p. 146-
1 p.
artikel
58 Statins in Traumatic Brain Injury Wible, Elissa F.
2010
7 1 p. 62-73
12 p.
artikel
59 Statins in traumatic brain injury Wible, Elissa F.
2010
7 1 p. 62-73
artikel
60 Substance P Antagonists as a Therapeutic Approach to Improving Outcome Following Traumatic Brain Injury Vink, Robert
2010
7 1 p. 74-80
7 p.
artikel
61 Substance P antagonists as a therapeutic approach to improving outcome following traumatic brain injury Vink, Robert
2010
7 1 p. 74-80
artikel
62 The Evidence for Hypothermia as a Neuroprotectant in Traumatic Brain Injury Dietrich, W. Dalton
2010
7 1 p. 43-50
8 p.
artikel
63 The evidence for hypothermia as a neuroprotectant in traumatic brain injury Dietrich, W. Dalton
2010
7 1 p. 43-50
artikel
64 Third Annual Huntington Disease Clinical Research Symposium Dubinsky, Richard
2010
7 1 p. 135-147
artikel
65 Traumatic Brain Injury and Aging: Is a Combination of Progesterone and Vitamin D Hormone a Simple Solution to a Complex Problem? Cekic, Milos
2010
7 1 p. 81-90
10 p.
artikel
66 Traumatic brain injury and aging: Is a combination of progesterone and vitamin D hormone a simple solution to a complex problem? Cekic, Milos
2010
7 1 p. 81-90
artikel
67 Traumatic Brain Injury: Therapeutic Challenges and New Directions Vink, Robert
2010
7 1 p. 1-2
2 p.
artikel
68 Traumatic brain injury: Therapeutic challenges and new directions Vink, Robert
2010
7 1 p. 1-2
artikel
69 Use of Magnesium in Traumatic Brain Injury Sen, Ananda P.
2010
7 1 p. 91-99
9 p.
artikel
70 Use of magnesium in traumatic brain injury Sen, Ananda P.
2010
7 1 p. 91-99
artikel
                             70 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland